Historical record - last NADAC publication: 8/21/2019
Product Information
RAMIPRIL 1.25 MG CAPSULE is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.1141 per EA under NDC 00054010625. Its NADAC has been published 301 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Ramipril market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1.25 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054010625
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
8/21/2019
Active Ingredients
RAMIPRILApproval Type
Generic (ANDA)
FDA Application
ANDA077900On Market Since
6/18/2008
Pharmacological Classes
Price Statistics
The NADAC for RAMIPRIL 1.25 MG CAPSULE has been published 301 times since Nov 28, 2013, and over the history we have for it it has declined 46.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1141 per EA |
|---|---|
| All-time high | $0.2323 (Aug 13, 2014) |
| All-time low | $0.0899 (May 22, 2019) |
| Median price | $0.1794 |
| Average price | $0.1750 |
| Largest weekly change | +37.2% (Mar 20, 2019) |
| Weeks tracked | 301 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RAMIPRIL 1.25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RAMIPRIL 1.25 MG CAPSULE, manufactured by Hikma Pharmaceuticals USA Inc., is $0.1141 per EA (NDC 00054010625), effective Aug 28, 2019.
How has the price of RAMIPRIL 1.25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RAMIPRIL 1.25 MG CAPSULE has declined 46.2%. It has been tracked across 301 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RAMIPRIL 1.25 MG CAPSULE?
Since Nov 28, 2013, the NADAC for RAMIPRIL 1.25 MG CAPSULE has ranged from a low of $0.0899 (May 22, 2019) to a high of $0.2323 (Aug 13, 2014), with a median of $0.1794 per EA.
Are there cheaper alternatives to RAMIPRIL 1.25 MG CAPSULE?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RAMIPRIL 1.25 MG CAPSULE, is $0.0867 per EA — about 24% below RAMIPRIL 1.25 MG CAPSULE.
Who manufactures RAMIPRIL 1.25 MG CAPSULE?
RAMIPRIL 1.25 MG CAPSULE (NDC 00054010625) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification